Aa
Clinical trial design
In the clinical trial design about obesity with type 2 diabetes , the exclusion criteria includes patients should be excluded if they have fasting glucose levels greater than 270 mg/dl, I wonder the the clinical significance of the 270 mg/dl? In the T2DM clinical guidance, I didn't find this value.
COMMUNITY LEADER
Fasting levels of greater than 270, represent extremely poor control. Patients with this fasting level likely have multiple complications. I suspect this is why they would exclude people having these levels.
1 Comments
Thanks for your help, I will search the related articles about the extremely poor control.
You will have to ask the people doing the trials.
You are reading content posted in the Diabetes - Type 2 Community
Here are three summertime recipes that will satisfy your hunger without wreaking havoc on your blood sugar.
If you have prediabetes, type 2 diabetes isn’t inevitable. Find out how you can stop diabetes before it starts.
Diabetes-friendly recipes and tips for your game day party.
Are there grounds to recommend coffee consumption? Recent studies perk interest.
Simple ways to keep your blood sugar in check.
8 blood sugar-safe eats.
